Ciclopirox: A broad-spectrum antifungal with antibacterial and anti-inflammatory properties

International Journal of Dermatology

Volumn 43, Issue SUPPL. 1, 2004, Pages 3-8

  Gupta, Aditya K ^a,b,d   Plott, Todd ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

^c Medicis Pharmaceutical Corporation   (United States)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; CICLOPIROX; CICLOPIROXOLAMINE; CLOTRIMAZOLE; DESOXIMETASONE; ECONAZOLE; FLUCONAZOLE; HYDROCORTISONE; INDOMETACIN; KETOCONAZOLE; NAFTIFINE; OXICONAZOLE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANDIDIASIS; CREAM; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG SAFETY; GEL; HUMAN; NONHUMAN; ONYCHOMYCOSIS; SEBORRHEIC DERMATITIS; SKIN DISEASE; STRUCTURE ACTIVITY RELATION; SUSPENSION; TINEA CORPORIS; TINEA CRURIS; TINEA PEDIS; TINEA VERSICOLOR;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFUNGAL AGENTS; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; PYRIDONES;

EID: 4444235835     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1461-1244.2004.02380.x     Document Type: Article

References (24)

1. Gupta AK, Skinner AR, Cooper EA. Interdigital tinea pedis (dermatophytosis simplex and complex) and treatment with ciclopirox 0.77% gel. Int J Dermatol 2003; 42 (Suppl. 1): 23-27.
2. Aly R, Fisher G, Katz HI, et al. Ciclopirox gel in the treatment of patients with interdigital tinea pedis. Int J Dermatol 2003; 42 (Suppl. 1): 29-35.
3. Gupta AK. Ciclopirox: an overview. Int J Dermatol 2001; 40: 305-310.
4. Sakurai K, Sakaguchi T, Yamaguchi H, et al. Mode of action of 6-cyclohexyl-1hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296). Chemotherapy 1978; 24: 68-76.
5. Kokjohn K, Bradley M, Griffiths B, et al. Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria. Int J Dermatol 2003; 42 (Suppl. 1): 11-17.
6. Abrams B, Hänel H, Hoehler T. Ciclopirox olamine: a hydroxypyridone antifungal agent. Clin Dermatol 1992; 9: 471-477.
7. Niewerth M, Kunze D, Seibold M, Schaller M, Korting HC, Hube B. Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother 2003; 47: 1805-1817.
8. Gasparini G, Contini D, Torti A, et al. The effect of ciclopiroxolamine investigated by means of freeze-fracture technique. Mykosen 1986; 29: 539-544.
9. Del Palacio-Hernanz A, Guarro-Artigas J, Figueras-Salvat M, et al. Changes in fungal ultrastructure after short course ciclopiroxolamine therapy in pityriasis versicolor. Clin Exp Dermatol 1990; 15: 95-100.
10. Hoffman B, Hanauske-Able H, Flint A, et al. A new class of reversible cell cycle inhibitors. Cytometry 1991; 12: 26-32.
11. Jue SG, Dawson GW, Brogden RN. Ciclopirox olamine 1% cream: a preliminary review of its antimicrobial activity and therapeutic use. Drugs 1985; 29: 330-341.
12. Hänel H, Raether W, Dittmar W. Evaluation of fungicidal action in vitro and in a skin model considering the influence of penetration kinetics of various standard antimycotics. Ann NY Acad Sci 1988; 544: 329-337.
13. Aly R, Maibach HI, Bagatell FK, et al. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis. Clin Ther 1989; 11: 290-303.
14. Squire RA, Goode K. A randomized, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral®) for the treatment of dandruff/seborrheic dermatitis. J Dermatol Treatment 2002; 13: 51-60.
15. Lee JH, Lee HS, Eun HC, Cho KH. Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea. J Dermatol Treatment 2003; 14: 212-215.
16. Markus A. Hydroxy-pyridones: outstanding biological properties. In: Shuster S, ed. Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis. Berlin: Springer Verlag, 1999: 1-10.
17. Schalla W, Kraemer K, Pooth R. Can ciclopirox be used as a broad-spectrum anti-infective agent? In: Shuster S, ed. Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis. Berlin: Springer Verlag, 1999: 18-32.
18. Rees JL. Studies of the anti-inflammatory properties of Ciclopirox. In: Shuster S, ed. Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis. Berlin: Springer Verlag, 1999: 33-35.
19. Rosen T, Schell B, Orengo I. Anti-inflammatory activity of antifungal preparations. Int J Derm 1997; 36: 788-792.
20. Lassus A, Nolting KS, Savopoulos C. Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses. Clin Ther 1988; 10: 594-599.
21. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol 2004; 18: 13-26.
22. Korting HC, Grundmann-Kollmann M. The hydroxypyridones: a class of antimycotics of its own. Mycoses 1997; 40: 243-247.
23. Aly R, Katz HI, Kempers SE, et al. Ciclopirox gel for seborrheic dermatitis of the scalp. Int J Dermatol 2003; 42 (Suppl. 1): 19-22.
24. Gupta AK, Skinner AR. Ciclopirox for the treatment of superficial fungal infections: a review. Int J Dermatol 2003; 42 (Suppl. 1): 3-9.